AI-driven precision healthcare is here – what you need to know

Dr. Anmol Kapoor, an expert in precision medicine and artificial intelligence, discusses AI-driven genomic analysis, blockchain in genomics, multi-omic integration, and navigating ethical and regulatory challenges of AI-enabled personalized care.

Dr. Anmol Kapoor, founder of CardiAI and BioAro, is an expert in precision healthcare, artificial intelligence and blockchain technologies. He has filed more than 70 patents in areas ranging from AI and genomics to quantum sciences and digital health. Through his work, he aims to transform modern healthcare through personalized, precision-based approaches.

We spoke with Kapoor recently to tap his expertise and gain a deeper understanding of these emerging areas of care innovation. We discussed AI-driven genomic analysis, explored where there are strategic opportunities for the C-suite in precision medicine and discussed how distributed ledger technology can enhance data security and trust in health systems pursuing genomics.

He also discussed how multi-omic integration can offer a competitive advantage for those health systems – and described how clinical and C-suite leaders should be navigating ethical and regulatory challenges as AI-powered precision medicine becomes more common.

CLICK HERE TO READ THE COMPLETE STORY